NRG-GY022

Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin

Principal Investigator

Sarah Taylor

Status

Disease Site

Gynecologic [GY] Other

Phase

I

Developmental Therapeutics

No

Primary Objective

Evaluate the success of targeting a carboplatin AUC with our current approach to dosing carboplatin. 

Patient Population

Any patients who will receive treatment with intravenous carboplatin (any AUC, any cycle) on an NCI-sponsored NCTN-, ETCTN-, trial, local trial, or through standard of care.

Target Accrual

250